1. Home
  2. MEI vs CTNM Comparison

MEI vs CTNM Comparison

Compare MEI & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEI
  • CTNM
  • Stock Information
  • Founded
  • MEI 1946
  • CTNM 2009
  • Country
  • MEI United States
  • CTNM United States
  • Employees
  • MEI N/A
  • CTNM N/A
  • Industry
  • MEI Electrical Products
  • CTNM
  • Sector
  • MEI Technology
  • CTNM
  • Exchange
  • MEI Nasdaq
  • CTNM Nasdaq
  • Market Cap
  • MEI 402.1M
  • CTNM 378.7M
  • IPO Year
  • MEI N/A
  • CTNM 2024
  • Fundamental
  • Price
  • MEI $12.17
  • CTNM $13.50
  • Analyst Decision
  • MEI Hold
  • CTNM Strong Buy
  • Analyst Count
  • MEI 3
  • CTNM 4
  • Target Price
  • MEI $14.00
  • CTNM $29.25
  • AVG Volume (30 Days)
  • MEI 581.0K
  • CTNM 134.3K
  • Earning Date
  • MEI 12-05-2024
  • CTNM 02-16-2025
  • Dividend Yield
  • MEI 4.61%
  • CTNM N/A
  • EPS Growth
  • MEI N/A
  • CTNM N/A
  • EPS
  • MEI N/A
  • CTNM N/A
  • Revenue
  • MEI $1,087,900,000.00
  • CTNM N/A
  • Revenue This Year
  • MEI N/A
  • CTNM N/A
  • Revenue Next Year
  • MEI $6.62
  • CTNM N/A
  • P/E Ratio
  • MEI N/A
  • CTNM N/A
  • Revenue Growth
  • MEI N/A
  • CTNM N/A
  • 52 Week Low
  • MEI $8.54
  • CTNM $12.33
  • 52 Week High
  • MEI $23.41
  • CTNM $22.00
  • Technical
  • Relative Strength Index (RSI)
  • MEI 54.53
  • CTNM N/A
  • Support Level
  • MEI $11.79
  • CTNM N/A
  • Resistance Level
  • MEI $13.51
  • CTNM N/A
  • Average True Range (ATR)
  • MEI 1.04
  • CTNM 0.00
  • MACD
  • MEI -0.09
  • CTNM 0.00
  • Stochastic Oscillator
  • MEI 21.19
  • CTNM 0.00

About MEI Methode Electronics Inc.

Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: